ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,090.27
0.25%
US Tech 100
21,038.00
0.79%
Dow Jones
44,642.52
-0.28%
Brent Oil
70.95
0.00%
Bitcoin
99,743.17
-0.18%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Amyris Inc (AMRS) Quote

Amyris Inc

Amyris Inc (AMRS)

NASDAQ
0.05
0.00
(0.00%)
Closed December 08 4:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.05
Bid
0.053
Ask
0.054
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.05
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

AMRS Latest News

More News

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary

VALENCIA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound...

July 01 2024
GlobeNewswire Inc.

Form 8-K - Current report

April 23 2024
Edgar (US Regulatory)

Form 8-K - Current report

April 08 2024
Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

April 02 2024
Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

January 05 2024
Edgar (US Regulatory)

Form 8-K - Current report

January 04 2024
Edgar (US Regulatory)

Form 8-K - Current report

December 29 2023
Edgar (US Regulatory)

Form 8-K - Current report

December 27 2023
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

August 17 2023
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

August 17 2023
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UPCUniverse Pharmaceuticals Inc
$ 3.38
(221.90%)
93.07M
LIFWMSP Recovery Inc
$ 3.2461
(104.16%)
29.08M
GXAIGaxos ai Inc
$ 2.5801
(81.70%)
145.87M
SBETSharpLink Gaming Inc
$ 0.9116
(73.97%)
27.08M
HCTIHealthcare Triangle Inc
$ 1.165
(68.38%)
4.34M
ORISOriental Rise Holdings Ltd
$ 3.6833
(-93.42%)
27.51M
LICNLichen China Limited
$ 0.4895
(-76.91%)
185.96M
MYNAMynaric AG
$ 0.499246
(-64.59%)
3.6M
CEROCERo Therapeutics Holdings Inc
$ 0.1146
(-40.16%)
37.87M
BTCTBTC Digital Ltd
$ 10.50
(-32.95%)
3.26M
SMXSMX Security Matters Public Company
$ 0.4879
(64.06%)
448.58M
SOUNSoundHound AI Inc
$ 15.01
(12.60%)
218.94M
NVDANVIDIA Corporation
$ 142.44
(-1.81%)
187.57M
LICNLichen China Limited
$ 0.4895
(-76.91%)
186.02M
SVMHSRIVARU Holding Ltd
$ 0.0293
(-16.29%)
162.46M

Discussion

View Full Feed
02opida 02opida 2 minutes ago
GMAB - Investigational Epcoritamab (DuoBody(TM) CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
02opida 02opida 3 minutes ago
Enjoy the day with family & Friends :)
capgain capgain 3 minutes ago
GM, Works for me.
Brucebannerr Brucebannerr 3 minutes ago
Bawhahaha golden losers !
Of course there is nothing to do with worthless untradeable shares .
02opida 02opida 3 minutes ago
ZNOG
ZNOG
02opida 02opida 3 minutes ago
ERHE
ERHE
02opida 02opida 3 minutes ago
MVNT
MVNT
02opida 02opida 4 minutes ago
AAPB
02opida 02opida 4 minutes ago
AAON
02opida 02opida 4 minutes ago
AAOI
AAOI
02opida 02opida 4 minutes ago
ZNOG
ZNOG
02opida 02opida 4 minutes ago
AAGR
AAGR
Jasbg Jasbg 4 minutes ago
No matter how you look at it - it is depressing that a court decision (build on fraud) - from marts 2020 - takes (it seems) up to ten years to 'analyse' and treat in the US legal apparatus.
No wonder that there is more than double the number of lawyers in the US than any where else in the Wo
AMRN
02opida 02opida 4 minutes ago
SHWZ
SHWZ
02opida 02opida 5 minutes ago
NEXI
NEXI
02opida 02opida 5 minutes ago
EMGE
EMGE
europa7 europa7 5 minutes ago
Citi predicts big changes for corporate treasures in 3+ years, with DLT playing a role
December 4, 2024
https://www.ledgerinsights.com/citi-predicts-big-changes-for-corporate-treasures-in-3-years-with-dlt-playing-a-role/

A role for DLT and tokenization?
"...Citi e
HBARUSD
02opida 02opida 5 minutes ago
CENT
02opida 02opida 5 minutes ago
IFRX
IFRX
02opida 02opida 5 minutes ago
OGEN
OGEN
02opida 02opida 5 minutes ago
XPON
XPON
02opida 02opida 6 minutes ago
KXIN
KXIN
02opida 02opida 6 minutes ago
NEON
02opida 02opida 6 minutes ago
MLSS
MLSS
02opida 02opida 6 minutes ago
ILAG

Your Recent History

NASDAQ
AMRS
Amyris
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved